MedTrace Logo

Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours

NCT03238378 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2018-06-08

No results posted yet for this study

Summary

The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.

Conditions

  • Locally Recurrent Head and Neck Cancer

Interventions

RADIATION

Brachytherapy

Brachytherapy d 1-5(6)

OTHER

Hyperthermia

Hyperthermia d 2 + 5

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Vratislav Strnad, MD · Dept. of Radiation Therapy, University Hospital Erlangen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-29
Primary Completion
2022-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03238378 on ClinicalTrials.gov